Pharmaceutical Clinical Advisors

 

Dr. Arkadiusz Dudek, M.D., Ph.D.
University of Minnesota

Dr. Dudek is an Associate Professor of Medicine and Director of the Clinical Trials Office in the Hematology, Oncology and Transplantation Division at the University of Minnesota. He received his M.D. from the Medical University of Warsaw, Poland. Dr. Dudek completed his internal medicine residency in Harrisburg, Pennsylvania and subspecialty training in Hematology, Oncology and Transplantation at the University of Minnesota. He received his Ph.D. from Military Medical Academy of Warsaw.

 

Roy S. Herbst, M.D., Ph.D.
M.D. Anderson Cancer Center

Dr. Herbst is Professor of Medicine and Chief of Section of Thoracic Medical Oncology at the University of Texas M.D. Anderson Cancer Center in Houston. He received his Ph.D. in Molecular Cell Biology from Rockefeller University, his M.D. from Cornell University Medical College and master degrees from Harvard Medical School in Clinical Investigation/Medical Science. His research focus is on the diagnosis and treatment of lung cancers.

 

Michael R. Kurman, M.D.
Michael Kurman Consulting

Dr. Kurman is President of Michael Kurman Consulting and advises numerous pharmaceutical development companies, including Avalon Pharmaceuticals, Thallion Pharmaceuticals and Locus Pharmaceuticals. He previously held several senior clinical research positions at Quintiles, US Bioscience and Cytogen Corporation. Dr. Kurman received his M.D. from Cornell University Medical College.

 

Richard H. Patt, M.D.
Foresight Consulting

Dr. Patt has more than 15 years of experience as both an academic and clinical radiologist, in managed care, and in directing clinical development programs. Dr. Patt was Director, Magnetic Resonance Imaging at Georgetown University Medical Center and Assistant Professor of Radiology. He has been internationally recognized for his research using MRI for breast cancer detection, and served on the National Cancer Institute (NCI) Breast MRI Advisory Board. Dr. Patt received his M.D. from Georgetown University School of Medicine, where he completed both his radiology residency and subspecialty fellowship.

 

Jerome Ritz, M.D.
Dana-Farber Cancer Institute

Dr. Ritz is Professor of Medicine, Harvard Medical School; Professor of Medicine, Dana-Farber Cancer Institute; and Director, Cell Manipulation Core Facility, Dana-Farber Harvard Cancer Center, Boston. Dr. Ritz received his M.D. from Chicago Medical School, followed by residency in internal medicine at the University of Wisconsin Hospitals, Madison. He completed a clinical fellowship in hematology and oncology at Beth Israel Hospital, and a research fellowship at Dana-Faber Cancer Institute. Dr. Ritz also has a M.A. from Harvard University.

 

Leonard B. Saltz, M.D.
Memorial Sloan-Kettering Cancer Center

Dr. Saltz is a Member of Memorial Sloan-Kettering Cancer Center and Attending Physician at Memorial Hospital for Cancer and Allied Diseases, New York, NY. A Professor of Medicine at Cornell University’s Weill College of Medicine, Dr. Saltz is an internationally recognized expert in the development of new treatments for colorectal cancer. He received his doctorate from Yale University School of Medicine and completed residencies at The New York Hospital/Cornell Medical Center. Dr. Saltz completed fellowships at The New York Hospital/Cornell Medical Center, The Rockefeller University. He was instrumental in the development of Erbitux®, a monoclonal antibody from ImClone Systems.


Eric Van Cutsem, M.D., Ph.D.

University Hospital Gasthuisberg

Professor Van Cutsem is currently Professor of Internal Medicine at the University of Leuven, Belgium, and head of the division of Digestive Oncology at the University Hospital Gasthuisberg in Leuven.  He obtained the degree of medical doctor at the University of Leuven, specializing in internal medicine. Professor Van Cutsem is holder of the special chair Digestive Oncology at the University of Leuven and has a mandate as senior clinical researcher of the Fund for Scientific Research.

 

Jun Yan, M.D., Ph.D.

James Graham Brown Cancer Center

Dr. Yan is an Associate Professor, Department of Medicine, and Department of Microbiology & Immunology at the James Graham Brown Cancer Center located within the University of Louisville.  Dr. Yan received an M.D from Jiangsu University School of Medicine and a Ph.D. in immunology from Shanghai Second Medical University.

 


Site design by Checkerboard